• How Ryght is Building a Generative AI Platform for BioPharma

  • Mar 18 2024
  • Length: 27 mins
  • Podcast

How Ryght is Building a Generative AI Platform for BioPharma  By  cover art

How Ryght is Building a Generative AI Platform for BioPharma

  • Summary

  • Our guest for this podcast episode is Simon Arkell, CEO of Ryght. Ryght is developing the next generation of safe and secure generative AI to empower Life Science companies to ingest real-time data and make actionable knowledge directly available to discovery, clinical, and commercial teams.
    Show more Show less
activate_primeday_promo_in_buybox_DT

What listeners say about How Ryght is Building a Generative AI Platform for BioPharma

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.